Phase 2 Hypofractionation Study Using Proton Beam Therapy for Prostate Adenocarcinoma

Phase 2 Hypofractionation Study Using Proton Beam Therapy for Prostate Adenocarcinoma

Phase 2 hypofractionation study usion proton beam therapy for prostate adenocarcinoma

Inclusion Criteria:

Biopsy proven prostate adenocarcinoma Stage: T1-T2cN0M0 ECOG performance status: 0-2 Signed study specific informed consent prior to study entry

Exclusion Criteria:

Postoperative residual or recurrent tumor Evidence of distant metastases Previous irradiation for the tumor in the same location Adjuvant anti-androgenic hormonal therapy High risk group (NCCN guide line)